Back
Royalty Pharma PLC 10K Form
Sell
24
RPRX
Royalty Pharma PLC
Last Price:
28.10
Seasonality Move:
-6.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | RPRX/Royalty Pharma PLC Quarterly |
| 2023-08-08 | 10Q | RPRX/Royalty Pharma PLC Quarterly |
| 2023-05-09 | 10Q | RPRX/Royalty Pharma PLC Quarterly |
| 2022-11-08 | 10Q | RPRX/Royalty Pharma PLC Quarterly |
| 2022-08-04 | 10Q | RPRX/Royalty Pharma PLC Quarterly |
| 2022-05-05 | 10Q | RPRX/Royalty Pharma PLC Quarterly |
Receive RPRX News And Ratings
See the #1 stock for the next 7 days that we like better than RPRX
RPRX Financial Statistics
Sales & Book Value
| Annual Sales: | $2.35B |
|---|---|
| Cash Flow: | $772.63M |
| Price / Cash Flow: | 5.65 |
| Annual Sales: | $14.61 |
| Price / Book: | 1.92 |
Profitability
| EPS (TTM): | 2.52000 |
|---|---|
| Net Income (TTM): | $1.13B |
| Gross Margin: | $0 |
| Return on Equity: | 11.62% |
| Return on Assets: | 6.82% |
Royalty Pharma PLC Earnings Forecast
Key Royalty Pharma PLC Financial Ratios
- The Gross Profit Margin over the past 11 years for RPRX is 0.00%.
- The Selling, General & Administrative Expenses for RPRX have been equal to 10.61% of Gross Profit Margin.
- The Research & Development expenses have been 2.21% of Revenue.
- The Interest Expense is 16.49% of Operating Income.
- The Net Earning history of RPRX is 48.20% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 10 years.
Royalty Pharma PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RPRX |
| CUSIP: | G7709Q |
| Website: | royaltypharma.com |
Debt
| Debt-to-Equity Ratio: | 0.94 |
|---|---|
| Current Ratio: | 7.9 |
| Quick Ratio: | 7.87 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.06 |
|---|---|
| Forward P/E Ratio: | 6.45 |
RPRX Technical Analysis vs Fundamental Analysis
Sell
24
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a Sell
The current Royalty Pharma PLC [RPRX] share price is $27.98. The Score for RPRX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.